Legal Representation
Attorney
Timothy J. Lyden
USPTO Deadlines
Next Deadline
2777 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2013-02-19)
Due Date
February 19, 2033
Grace Period Ends
August 19, 2033
Application History
35 eventsDate | Code | Type | Description |
---|---|---|---|
Aug 18, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Aug 18, 2023 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Aug 18, 2023 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
Aug 18, 2023 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
Jan 31, 2023 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
Feb 19, 2022 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
Sep 21, 2021 | NA15 | E | SEC. 15 ACKNOWLEDGEMENT - E-MAILED |
Sep 20, 2021 | 15AK | O | REGISTERED - SEC. 15 ACKNOWLEDGED |
Sep 15, 2021 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Aug 2, 2021 | E15R | I | TEAS SECTION 15 RECEIVED |
Jul 14, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jul 14, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jul 14, 2021 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Jul 14, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Mar 19, 2019 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
Mar 19, 2019 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
Mar 16, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Feb 19, 2019 | ES8R | I | TEAS SECTION 8 RECEIVED |
Feb 19, 2018 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Feb 19, 2013 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Dec 4, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION |
Dec 4, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Nov 14, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Oct 31, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Oct 30, 2012 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Oct 19, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 19, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 18, 2012 | ALIE | A | ASSIGNED TO LIE |
Oct 4, 2012 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Aug 31, 2012 | CNSL | R | SUSPENSION LETTER WRITTEN |
Aug 31, 2012 | GNSL | F | LETTER OF SUSPENSION E-MAILED |
Aug 31, 2012 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Aug 25, 2012 | DOCK | D | ASSIGNED TO EXAMINER |
Jul 2, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jun 28, 2012 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations being or containing Factor X, also known as thrombokinase, for use in the treatment of blood clotting disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...